Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.2 (
endonuclease
)
18,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The 2'-5'-oligoadenylate (2-5A) synthetases are a family of interferon-alpha (IFN-alpha) inducible enzymes that block viral replication by activating a latent
endonuclease
during viral infections. In Ramos cells, induction of mRNAs for the intermediate isoform of 2-5A synthetase (
p69
) requires five-fold higher IFN-alpha than is required for induction of the small isoform (p40). The p40 and
p69
isoforms are similarly induced between 1 and 24 h with maximal induction at 8 h. At 48 h, however,
p69
is more strongly induced than p40. Induction of
p69
and p40 between 1 and 24 h is protein synthesis independent whereas at 48 h,
p69
induction becomes dependent on protein synthesis. Initial induction of both isoforms requires tyrosine kinase activation and is enhanced by activation of a separate signalling pathway by the tumour promoter, 12-0-tetradecanoyl phorbol-13-acetate (TPA). These data suggest that induction of the p40 is predominantly protein synthesis independent, whereas
p69
induction occurs in two phases, an initial protein synthesis independent phase and a delayed protein synthesis dependent phase.
...
PMID:Protein synthesis-dependent and -independent induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha. 1052 12